Editor’s Note: ‘The Road Ahead’ whitepaper was first published in January 2017. Much has happened with Brexit since then. You can stay up to date on all of the Acorn Regulatory Brexit content here. Now that the British Prime Minister has finally outlined her plans for the British departure from the European Union, we can better consider the implications that Brexit will have on the life sciences sector in our latest Brexit whitepaper. In this whitepaper ‘The Road Ahead’, our team of regulatory affairs experts look at issues such as the future of EU Authorised Representatives, they also look at how the ABPI has responded to the crisis and there is an update on the likely host cities for the European Medicines Agency. Our latest Brexit whitepaper also looks at the details in the Lancaster House speech and assesses how life sciences might be impacted. Download your copy of ‘The Road Ahead’ by completing the details below. [ninja_form id=2] We have also produced further Brexit publications: What Happens Next? was published in 2019 Is Time Running Out? was published in 2018 Heading for the Exit was published in Q4 2016. The Implications of Brexit was published in Q3 2016 As the thought leaders on the Brexit issue in the regulatory affairs sector we have also produced a number of articles relating to the UK’s decision to leave the EU. You can read more HERE.